Unscheduled bleeding in continuous combined hormone therapy users.
Continuous combined hormone therapy (HT) is effective for menopausal vasomotor symptoms and vaginal dryness but commonly leads to unscheduled vaginal bleeding and spotting. Unscheduled bleeding is disliked by women and may lead to invasive investigations to exclude underlying pelvic pathology. In most cases investigations do not reveal any underlying cause for the bleeding.
Department of Obstetrics and Gynaecology, The University of Melbourne & Royal Women's Hospital, Parkville, Victoria, Australia. Martha.Hickey@thewomens.org.au
Martha
M
Hickey
Devini
D
Ameratunga
Jennifer L
JL
Marino
D004717:Endometrium / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000503:physiopathology; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D017698:Postmenopause; D011372:Progestins / Q000009:adverse effects*; D014463:Ultrasonography; D014592:Uterine Hemorrhage / Q000139:chemically induced* / Q000503:physiopathology / Q000628:therapy
D011372:Progestins